Evidence map›Paper›PMID 42210355›Full record

ArticleBMC veterinary research2026

Q fever in Kazakhstan: seroepidemiology, molecular evidence, and spatial distribution across livestock and ticks.

Yuliya V Perfilyeva, Akzhigit S Mashzhan, Moldir M Kuatbek, Yekaterina O Ostapchuk, Zhaniya M Dosmagambet, Andrey V Zhigailov, Artyom V Kuligin, Akerke O Bissenbay, Saltanat A Kuatbekova, Sofiya A Kan and 10 more

Abstract read
In one paragraph

Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Yuliya V PerfilyevaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan. perfilyevayulya@gmail.com.
Akzhigit S MashzhanAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan. aj.akzhigit@gmail.com.
Moldir M KuatbekAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Yekaterina O OstapchukAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Zhaniya M DosmagambetAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Andrey V ZhigailovAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Artyom V KuliginAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Akerke O BissenbayAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Saltanat A KuatbekovaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Sofiya A KanAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Anzhelika V LushovaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Nurshat AbdollaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Anna S NizkorodovaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Zhanna Zh ShapiyevaScientific Practical Center of Sanitary-Epidemiological Expertise and Monitoring, 84 Auezov St, Almaty, 050008, Kazakhstan.
Zaure Z SayakovaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Anastassiya V PerfilyevaInstitute of Genetics and Physiology, 93 Al-Farabi Avenue, Almaty, 050060, Kazakhstan.
Zhanna A BerdygulovaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Elina R MaltsevaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Yuriy A SkibaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.
Andrey M DmitrovskiyAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, 14 Zhahanger St, Almaty, 050054, Kazakhstan.

Funding

Science Committee of the Ministry of Science and High Education of Kazakhstan AP23487856
6 · The paper itself

Abstract

backgroundQ fever, caused by Coxiella burnetii, remains a neglected zoonosis in Kazakhstan, with limited epidemiological data available. This study assessed the occurrence, spatial distribution, and risk factors of Q fever nationwide.

resultsBetween 2019 and 2024, 1,314 cattle and 1,689 small ruminants were sampled from 115 to 149 villages/cities, respectively, and 3,073 ticks were collected from 39 districts across Kazakhstan. Blood serum samples were screened for anti-C. burnetii antibodies by ELISA, while DNA from sheep milk and ticks was analyzed by qPCR, followed by partial sequencing of the 16 S rRNA and IS1111 genes. Multiple spacer sequence typing was performed on selected C. burnetii - positive samples. Risk factors were evaluated in a GEE model, and spatial risk maps were generated via inverse distance weighting interpolation. The apparent individual seroprevalence was significantly higher in small ruminants (30.6%; 95% CI: 28.4 - 32.9) than in cattle (6.6%; 95% CI: 5.3 - 8.1; p < 0.0001). Herd-level prevalence was 12.9% (95% CI: 8.4 - 17.6) in cattle and 60.2% (95% CI: 52.5 - 67.6; p < 0.0001) in small ruminants. Pavlodar oblast exhibited the highest individual and herd-level seroprevalence in both species, whereas low seroprevalence (≤ 11%) was observed in Atyrau, Mangystau, East Kazakhstan, and North Kazakhstan oblasts. Herd size was identified as a significant risk factor in both cattle and small ruminants. Coxiella burnetii DNA was detected in three of 77 (4%; 95% CI: 0.8 - 10.9) tested sheep milk samples. Overall, 7.6% of ticks (234/3,073; 95% CI: 6.7 - 8.6) tested positive for Coxiella spp., primarily H. scupense and D. niveus, likely including non-pathogenic endosymbionts. Thirteen samples were successfully sequenced and showed 99.7%-100% nucleotide identity in the IS1111 gene with reference C. burnetii isolates. The allele profile identified in the present study for the loci Cox2 - Cox5 - Cox18 was 3-8-15.

conclusionQ fever should be regarded as a potentially underrecognized and underreported infection in Kazakhstan. The exceptionally high prevalence observed in Pavlodar oblast in small ruminants and cattle underscores the urgent need to initiate monitoring of Q fever in the human population.

Indexed as

Cattle DiseasesQ FeverSheep DiseasesTicksAnimalsAntibodies, BacterialCattleCoxiella burnetiiKazakhstanLivestockPrevalenceRisk FactorsSeroepidemiologic StudiesSheepAntibodies, BacterialCoxiella burnetiiKazakhstanLivestockSpatial distribution

Identifiers

PMID42210355
PMCPMC13348768

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.